A senior resident receives a COVID-19 vaccine shot at a vaccination site in Hohhot, North China's Inner Mongolia autonomous region, March 22, 2022. (Photo/Xinhua)
China's COVID-19 vaccines can provide seniors with significant protection against pneumonia and severe symptoms caused by the Omicron variant of COVID-19, according to a new study released by Chinese scientists on Friday.
Its findings add to growing evidence that it is imperative for the elderly to get vaccinated and then get their booster shots to protect themselves, according to the study published in China CDC Weekly, the national public health bulletin and an academic platform established by the Chinese Center for Disease Control and Prevention.
For Omicron cases among those age 60 and above, getting fully vaccinated with domestic vaccines was associated with a 70 to 80 percent decrease in developing pneumonia, according to the study that examined all COVID-19 infections on the Chinese mainland from late May 2021 to the end of February.
No serious Omicron infections had been recorded among seniors who had received a booster shot, it added.
China has so far approved three types of COVID-19 vaccines for public use－the two-dose inactivated vaccines, a one-dose adenovirus-vectored vaccine and a three-dose recombinant subunit vaccine. All three were included in the study.
The study also showed that domestic vaccines have shown efficacy in lowering the risk of pneumonia and severe illnesses caused by the Delta variant.
Researchers of the study, all from the China CDC, suggested all individuals age 3 and above without contraindications complete the full vaccination regimen and receive booster shots.
"The pace of booster dose administration, especially among the elderly, should be accelerated," it added.
Another report published by China CDC Weekly on Friday looked into vaccination coverage in the Hong Kong Special Administrative Region and also revealed the crucial protection that vaccines offer the elderly.
In Hong Kong, both domestic and foreign vaccines, including doses based on the novel mRNA technology and inactivated technology, have been widely administered.
By analyzing COVID-19-associated deaths in Hong Kong from January to March－when the fifth wave of its COVID-19 outbreak emerged and swept through the region－the report found that 96 percent of deaths occurred among people age 60 and above.
Within this age group, "the risk of death was 20 times lower among those who were fully vaccinated compared with those who were unvaccinated", it said.
As vaccination coverage declined among those of increasing age in Hong Kong, it said that "efforts to identify and address gaps in age-specific vaccination coverage can help prevent high mortality from COVID-19, especially in older adults".
The report was jointly authored by researchers from the United States, Hong Kong and the mainland. It was published simultaneously in China CDC Weekly, the US CDC's Morbidity and Mortality Weekly Report, and the World Health Organization's Weekly Epidemiological Record.
京公網(wǎng)安備 11010202009201號(hào)